Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.960
-0.630 (-13.73%)
At close: Nov 20, 2024, 4:00 PM
3.880
-0.080 (-2.02%)
Pre-market: Nov 21, 2024, 5:29 AM EST
Aclaris Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ACRS stock have an average target of 7.20, with a low estimate of 1.00 and a high estimate of 13. The average target predicts an increase of 81.82% from the current stock price of 3.96.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACRS stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $2 → $7 | Hold → Buy | Upgrades | $2 → $7 | +76.77% | Nov 19, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $7 | Hold → Strong Buy | Upgrades | $2 → $7 | +76.77% | Nov 19, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +102.02% | Nov 19, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $3 → $13 | Hold → Buy | Upgrades | $3 → $13 | +228.28% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 17, 2024 |
Financial Forecast
Revenue This Year
14.58M
from 31.25M
Decreased by -53.34%
Revenue Next Year
9.96M
from 14.58M
Decreased by -31.71%
EPS This Year
-0.64
from -1.27
EPS Next Year
-0.66
from -0.64
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 39.1M | 20.9M | 22.9M | ||
| Avg | 14.6M | 10.0M | 9.9M | ||
| Low | 6.4M | 2.5M | 2.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.0% | 43.3% | 129.9% | ||
| Avg | -53.3% | -31.7% | -0.4% | ||
| Low | -79.6% | -82.7% | -74.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.40 | -0.51 | -0.45 | ||
| Avg | -0.64 | -0.66 | -0.74 | ||
| Low | -0.75 | -0.87 | -0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.